• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.人类芳香化酶基因(Cyp19)的体质性遗传变异与乳腺癌风险。
Br J Cancer. 1999 Feb;79(3-4):456-63. doi: 10.1038/sj.bjc.6690071.
2
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.细胞色素P450 19(CYP19)基因中的四核苷酸重复多态性与乳腺癌风险
Int J Cancer. 2000 Jul 15;87(2):204-10.
3
The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.韩国女性中CYP19基因多态性与乳腺癌风险之间的关联。
Oncol Rep. 2009 Sep;22(3):487-92.
4
Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.人类芳香化酶细胞色素P450基因(CYP19)多态性与乳腺癌风险
Carcinogenesis. 2000 Feb;21(2):189-93. doi: 10.1093/carcin/21.2.189.
5
Polymorphic variation in CYP19 and the risk of breast cancer.细胞色素P450 19(CYP19)的多态性变异与乳腺癌风险
Carcinogenesis. 2001 Feb;22(2):347-9. doi: 10.1093/carcin/22.2.347.
6
CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.CYP19(TTTA)n多态性与巴西女性患乳腺癌风险
Toxicol Lett. 2006 Jun 20;164(1):90-5. doi: 10.1016/j.toxlet.2005.11.014. Epub 2006 Jan 6.
7
CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study.细胞色素P450 1B1(CYP1B1)和细胞色素P450 19(CYP19)基因多态性与乳腺癌发病率:动脉粥样硬化风险社区(ARIC)研究中无关联
Cancer Lett. 2004 Apr 30;207(2):183-9. doi: 10.1016/j.canlet.2003.12.009.
8
The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.细胞色素P450 19(CYP19)基因第39密码子色氨酸/精氨酸多态性增加了绝经前日本女性亚组患乳腺癌的风险。
Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1407-11.
9
A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.
Toxicol Lett. 2004 Jun 15;151(1):267-71. doi: 10.1016/j.toxlet.2004.01.024.
10
Genetic variants of CYP19 (aromatase) and breast cancer risk.细胞色素P450 19(芳香化酶)的基因变异与乳腺癌风险
Oncogene. 2000 Mar 2;19(10):1329-33. doi: 10.1038/sj.onc.1203425.

引用本文的文献

1
Influence of dietary patterns in the pathophysiology of Huntington's Disease: A literature review.饮食模式在亨廷顿舞蹈病病理生理学中的影响:一项文献综述。
AIMS Neurosci. 2024 Apr 12;11(2):63-75. doi: 10.3934/Neuroscience.2024005. eCollection 2024.
2
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.构建用于评估和临床管理接受抗雌激素和/或芳香化酶抑制剂治疗的乳腺癌患者的数据库。
Clin Cases Miner Bone Metab. 2011 Jan;8(1):37-50.
3
Aromatase activity and bone loss in men.男性体内的芳香化酶活性与骨质流失
J Osteoporos. 2011;2011:230671. doi: 10.4061/2011/230671. Epub 2011 Jun 24.
4
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.乳腺癌预防试验中基因组多态性与癌症风险相互作用的新型通路分析。
Int J Mol Epidemiol Genet. 2010;1(4):332-49. Epub 2010 Sep 5.
5
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.芳香酶基因 CYP19 中的功能性遗传多态性使乳腺癌患者对芳香酶抑制剂新辅助治疗的反应产生差异。
Cancer Res. 2010 Jan 1;70(1):319-28. doi: 10.1158/0008-5472.CAN-09-3224.
6
An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men.芳香化酶多态性调节肥胖男性体重与雌二醇水平之间的关系。
Fertil Steril. 2010 Oct;94(5):1734-8. doi: 10.1016/j.fertnstert.2009.10.037. Epub 2009 Dec 11.
7
Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.中国上海女性中CYP19A1基因变异与乳腺癌及乳腺纤维囊性病变风险
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3457-66. doi: 10.1158/1055-9965.EPI-08-0517.
8
Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.绝经后中国女性CYP19A1基因多态性与性激素水平的关联
Pharmacogenet Genomics. 2008 Aug;18(8):657-64. doi: 10.1097/FPC.0b013e3282fe3326.
9
Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.CYP19A1基因变异与乳腺癌风险的单倍型分析:上海乳腺癌研究结果
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):27-32. doi: 10.1158/1055-9965.EPI-07-0688.
10
Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis.韩国女性中编码雌激素代谢酶CYP19基因的多态性和单倍型:与晚期子宫内膜异位症无关联。
J Hum Genet. 2007;52(9):703-711. doi: 10.1007/s10038-007-0174-x. Epub 2007 Aug 9.

本文引用的文献

1
Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction.芳香化酶基因在人类乳腺肿瘤中的表达及其外显子I的使用情况。通过逆转录-聚合酶链反应检测芳香化酶信使核糖核酸。
J Steroid Biochem Mol Biol. 1996 Oct;59(2):163-71. doi: 10.1016/s0960-0760(96)00100-8.
2
Presence of alternatively spliced transcripts of aromatase gene in human breast cancer.人乳腺癌中芳香化酶基因可变剪接转录本的存在。
J Clin Endocrinol Metab. 1996 Jun;81(6):2344-9. doi: 10.1210/jcem.81.6.8964875.
3
Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.利用替代启动子在无癌患者和乳腺癌患者的乳腺脂肪组织中表达芳香化酶细胞色素P450(CYP19)基因。
J Clin Endocrinol Metab. 1996 Nov;81(11):3843-9. doi: 10.1210/jcem.81.11.8923826.
4
Serum sex hormone levels after menopause and subsequent breast cancer.绝经后血清性激素水平与后续乳腺癌
J Natl Cancer Inst. 1996 Mar 6;88(5):291-6. doi: 10.1093/jnci/88.5.291.
5
Molecular cloning of a cDNA showing alternative splicing of the 5'-untranslated sequence of mRNA for human aromatase P-450.
Eur J Biochem. 1993 Apr 1;213(1):383-9. doi: 10.1111/j.1432-1033.1993.tb17772.x.
6
IGH minisatellite suppression of USF-binding-site- and E mu-mediated transcriptional activation of the adenovirus major late promoter.免疫球蛋白重链微卫星对腺病毒主要晚期启动子的USF结合位点和Eμ介导的转录激活的抑制作用。
Nucleic Acids Res. 1993 Feb 25;21(4):977-85. doi: 10.1093/nar/21.4.977.
7
Allelic variation of reporter gene activation by the HRAS1 minisatellite.HRAS1小卫星对报告基因激活的等位基因变异
Genomics. 1993 Aug;17(2):429-34. doi: 10.1006/geno.1993.1343.
8
An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.癌症风险与HRAS1小卫星位点突变之间的关联。
N Engl J Med. 1993 Aug 19;329(8):517-23. doi: 10.1056/NEJM199308193290801.
9
Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders.芳香化酶及其他类固醇生成酶在人类乳腺疾病中的免疫定位
Hum Pathol. 1994 May;25(5):530-5. doi: 10.1016/0046-8177(94)90127-9.
10
Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain.人脑中芳香化酶转录本特有的芳香化酶基因新外显子1。
Biochem Biophys Res Commun. 1994 Feb 15;198(3):1153-60. doi: 10.1006/bbrc.1994.1163.

人类芳香化酶基因(Cyp19)的体质性遗传变异与乳腺癌风险。

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.

作者信息

Siegelmann-Danieli N, Buetow K H

机构信息

Division of Population Science, Fox Chase Cancer Center, Philadelphia, PA, USA.

出版信息

Br J Cancer. 1999 Feb;79(3-4):456-63. doi: 10.1038/sj.bjc.6690071.

DOI:10.1038/sj.bjc.6690071
PMID:10027313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2362434/
Abstract

The activity of the aromatase enzyme, which converts androgens into oestrogens and has a major role in regulating oestrogen levels in the breast, is thought to be a contributing factor in the development of breast cancer. We undertook this study to assess the role of constitutional genetic variation in the human aromatase gene (Cyp19) in the development of this disease. Our genotyping of 348 cases with breast cancer and 145 controls (all Caucasian women) for a published tetranucleotide repeat polymorphism at intron 4 of the Cyp19 gene revealed the presence of six common and two rare alleles. Contingency table analysis revealed a significant difference in allelic distribution between cases and controls (chi2 5df = 13.52, P = 0.019). The allele measuring 171 bp was over-represented in cases; of 14 individuals homozygous for this allele, 13 were cases. These individuals had a higher incidence of cancer in family members and an earlier age at diagnosis than other cases. In sequencing Cyp19's coding exons and regulatory regions, we discovered a perfect association between a silent polymorphism (G-->A at Val80) and the high-risk genotype. Our conclusion is that constitutional genetic variation at the Cyp19 locus is associated with the risk of developing breast cancer, with the 171-bp allele serving as the high-risk allele.

摘要

芳香化酶可将雄激素转化为雌激素,在调节乳腺中的雌激素水平方面发挥着主要作用,该酶的活性被认为是乳腺癌发生的一个促成因素。我们开展这项研究,旨在评估人类芳香化酶基因(Cyp19)的体质性基因变异在这种疾病发生中的作用。我们对348例乳腺癌患者和145名对照者(均为白种女性)进行基因分型,检测已发表的Cyp19基因第4内含子的四核苷酸重复多态性,结果发现存在6种常见等位基因和2种罕见等位基因。列联表分析显示,病例组和对照组的等位基因分布存在显著差异(χ²5df = 13.52,P = 0.019)。长度为171 bp的等位基因在病例组中过度表达;在14名该等位基因纯合子个体中,有13例为病例。这些个体的家庭成员患癌几率更高,诊断时的年龄也比其他病例更早。在对Cyp19的编码外显子和调控区域进行测序时,我们发现一个沉默多态性(Val80处的G→A)与高危基因型之间存在完美关联。我们的结论是,Cyp19基因座的体质性基因变异与患乳腺癌的风险相关,171-bp等位基因为高危等位基因。